Cargando…

Effect of prostate-specific membrane antigen positron emission tomography on the decision-making of radiation oncologists

BACKGROUND: Positron emission tomography (PET) imaging is routinely used in many cancer types, although is not yet a standard modality for prostate carcinoma. Prostate-specific membrane antigen (PSMA) PET is a promising new modality for staging prostate cancer, with recent studies showing potential...

Descripción completa

Detalles Bibliográficos
Autor principal:	Shakespeare, Thomas P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652371/ https://www.ncbi.nlm.nih.gov/pubmed/26582424 http://dx.doi.org/10.1186/s13014-015-0548-8

Ejemplares similares

Making the Case for Prostate-Specific Membrane Antigen-Targeted Positron Emission Tomography/Computed Tomography in Suspected Prostate Cancer
por: Singh, Harmandeep
Publicado: (2020)

Online Prostate-Specific Membrane Antigen and Positron Emission Tomography–Guided Radiation Therapy for Oligometastatic Prostate Cancer
por: Hrinivich, William T., et al.
Publicado: (2019)

Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigen
por: Inubushi, Masayuki, et al.
Publicado: (2020)

(68)Ga-Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography: How Much Specific It Is?
por: Sahoo, Manas Kumar
Publicado: (2017)

Prostate-specific membrane antigen (PSMA)–ligand positron emission tomography and radioligand therapy (RLT) of prostate cancer
por: Tateishi, Ukihide
Publicado: (2020)

Metastatic superscan in prostate carcinoma on gallium-68-prostate-specific membrane antigen positron emission tomography/computed tomography scan
por: Agarwal, Krishan Kant, et al.
Publicado: (2016)

Upcoming Role of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Detecting Occult Metastases in Prostate Cancer
por: Gupta, Parul, et al.
Publicado: (2019)

Oligometastasis to testis in prostate cancer: Role of gallium-68 prostate-specific membrane antigen positron-emission tomography computed tomography
por: Gupta, Manoj, et al.
Publicado: (2020)

Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma
por: Udovicich, Cristian, et al.
Publicado: (2022)

Gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography compared with diagnostic computed tomography in relapsed prostate cancer
por: Asokendaran, Marcus Edward, et al.
Publicado: (2019)

Risk of Tumor Upstaging With Prostate-Specific Membrane Antigen Positron Emission Tomography in Patients With High-Risk Prostate Cancer
por: Brant, Aaron, et al.
Publicado: (2022)

Spinal Tuberculosis Mimicking as Prostate Cancer Metastases in Ga-68 Prostate-specific Membrane Antigen Positron-emission Tomography/Computed Tomography
por: Gupta, Nitin, et al.
Publicado: (2020)

Solitary Metastasis of Prostatic Adenocarcinoma to the Testicle Detected by (68)Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography
por: Deeb, Ibrahim Alsheikh, et al.
Publicado: (2020)

Accuracy Versus Impact: The Referee Verdict on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Staging of Prostate Cancer
por: O'Brien, Jonathan, et al.
Publicado: (2021)

Solitary Penile Metastasis from Prostate Cancer on (18)F-Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography
por: Dhull, Varun Singh, et al.
Publicado: (2022)

Gallium-68 Prostate-Specific Membrane Antigen Positron Emission Tomography: A Practical Guide for Radiologists and Clinicians
por: Palot Manzil, Fathima Fijula, et al.
Publicado: (2022)

Defining Prostatic Vascular Pedicle Recurrence and the Anatomy of Local Recurrence of Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography
por: Dundee, Philip, et al.
Publicado: (2022)

Ga-68 Prostate-Specific Membrane Antigen-HBED-CC Positron Emission Tomography/Computed Tomography in Anaplastic Thyroid Carcinoma
por: Subudhi, T. Kishan, et al.
Publicado: (2022)

(68)Ga-prostate-specific membrane antigen-positron emission tomography/computed tomography in advanced prostate cancer: Current state and future trends
por: Udovicich, Cristian, et al.
Publicado: (2017)

(68)Ga-prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Prostate Cancer Imaging: A Narrative Literature Review
por: Oliveira, Jose M., et al.
Publicado: (2017)

Localization and restaging of carcinoma prostate by (68)Gallium prostate-specific membrane antigen positron emission tomography computed tomography in patients with biochemical recurrence
por: Seniaray, Nikhil, et al.
Publicado: (2020)

Diagnostic performance of Gallium-68 prostate-specific membrane antigen positron emission tomography-computed tomography in intermediate and high risk prostate cancer
por: El Hajj, Albert, et al.
Publicado: (2019)

68-gallium Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography Detects Rare Testicular Metastasis from Prostate Cancer
por: Jain, Yash, et al.
Publicado: (2021)

The clinical characteristics of patients with primary non‐prostate‐specific membrane antigen‐expressing prostate cancer on preoperative positron emission tomography/computed tomography
por: Veerman, Hans, et al.
Publicado: (2021)

Fluorodeoxyglucose, sodium fluoride, and prostate-specific membrane antigen positron emission tomography studies for treatment response assessment in prostate cancer
por: Sarikaya, Ismet, et al.
Publicado: (2018)

New frontiers in focal therapy for prostate cancer: Prostate-specific membrane antigen positron emission tomography/magnetic resonance imaging
por: Manfredi, Celeste, et al.
Publicado: (2021)

Incremental value of 68-gallium-prostate-specific membrane antigen positron emission tomography/computed tomography in patients with abnormal prostate-specific antigen and benign transrectal ultrasound biopsy
por: Gupta, Manoj, et al.
Publicado: (2018)

Dual-Tracer Positron-Emission Tomography Using Prostate-Specific Membrane Antigen and Fluorodeoxyglucose for Staging of Prostate Cancer: A Systematic Review
por: McGeorge, Stephen, et al.
Publicado: (2021)

Prostate specific membrane antigen positron emission tomography for lesion-directed high-dose-rate brachytherapy dose escalation
por: Smith, Christopher W., et al.
Publicado: (2021)

Prostate-specific membrane antigen positron emission tomography/computed tomography as a potential tool to assess and guide salivary gland irradiation
por: Valstar, Matthijs H., et al.
Publicado: (2019)

Initial risk stratification and staging in prostate cancer with prostatic-specific membrane antigen positron emission tomography/computed tomography: A first-stop-shop
por: Gupta, Manoj, et al.
Publicado: (2018)

Standardised uptake values as determined on prostate‐specific membrane antigen positron emission tomography/computed tomography is associated with oncological outcomes in patients with prostate cancer
por: Bodar, Yves J.L., et al.
Publicado: (2022)

The oncological characteristics of non‐prostate‐specific membrane antigen (PSMA)‐expressing primary prostate cancer on preoperative PSMA positron emission tomography/computed tomography
por: Veerman, Hans, et al.
Publicado: (2022)

Prostate-specific Membrane Antigen Positron Emission Tomography, Not Conventional Imaging, Should Be Performed for Primary Staging of High-risk Prostate Cancer
por: Ceci, Francesco, et al.
Publicado: (2021)

Dose-Escalated Salvage Radiotherapy for Macroscopic Local Recurrence of Prostate Cancer in the Prostate-Specific Membrane Antigen Positron Emission Tomography Era
por: Tamihardja, Jörg, et al.
Publicado: (2022)

Impact of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography on the Therapeutic Decision of Prostate Carcinoma Primary Staging: A Retrospective Analysis at the Brazilian National Public Health System
por: da Silva, Anna Carolina Borges, et al.
Publicado: (2023)

Comparison of (68)Ga-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography for Primary Staging of Prostate Cancer: A Systematic Review and Meta-analysis
por: Ling, Sui Wai, et al.
Publicado: (2021)

Initial experience of Ga-68 prostate-specific membrane antigen positron emission tomography/computed tomography imaging in evaluation of biochemical recurrence in prostate cancer patients
por: Natarajan, Aravintho, et al.
Publicado: (2019)

Incremental Value of Ga-68 Prostate-Specific Membrane Antigen-11 Positron-Emission Tomography/Computed Tomography Scan for Preoperative Risk Stratification of Prostate Cancer
por: Pallavi, UN, et al.
Publicado: (2020)

Cost-Effectiveness Analysis of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) for the Primary Staging of Prostate Cancer in Australia
por: Song, Rachel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5hug6pp4hmnpp9aks3tko4jpco